From: Effects of treatment status and life quality on anxiety in MMT patients
MMT users (N=177) | |
---|---|
Gender (males/females) | 155(87.6%)/22(12.4%) |
Age | 51.8±5.7 |
Years of education | |
≤9 | 131(74.0%) |
10–12 | 44(24.9%) |
≥13 | 2(1.1%) |
Marital status (single/married) | 98(55.4%)/79(44.6%) |
Living situation (alone/with partners) | 57(32.2%)/120(67.8%) |
Drinking status (yes/no) | 58(32.8%)/119(67.2%) |
Smoking status (yes/no) | 174(98.3%)/3(1.7%) |
Cumulative duration of heroin use (month) | 261.4±82.6 |
Cumulative duration of MMT (month) | 100.9±60.7 |
Current methadone therapeutic dose (mg) | 37.3±22.1 |
MMT Interruption (yes/no) | 72(40.7%)/105(59.3%) |
BAI score | 7.1±8.2 |
QOL-DA total score | 163.5±21.4 |
Physiology Score | 33.3±6.5 |
Psychology Score | 39.6±6.8 |
Society Score | 39.2±6.9 |
Symptoms Score | 48.3±7.2 |